Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | GPR3 | P46089 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL5560176 | 1.00 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25285896 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL20570425 | 0.92 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL19915225 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25292546 | 0.92 | GPR3 (0.48) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25255863 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25287606 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25292878 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL25301943 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL23430060 | 0.92 | CA1 (0.44) | CA1CA2CA7CA13GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051419-A | Aqueous zinc ion battery electrolyte and preparation method and application thereof | 吉林化工大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122051424-A | Biomass-based composite hydrogel electrolyte and preparation method and application thereof | 郑州大学 | 2026-05-15 | — | — | CN | claimed |
| US-12476287-B2 | Dual electrolyte approach for high voltage batteries | URBAN ELECTRIC POWER INC. (US) | 2025-11-18 | — | — | US | claimed |
| US-12355061-B2 | High voltage batteries using gelled electrolyte | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2025-07-08 | — | — | US | claimed |
| CN-120039875-A | Regeneration method of waste artificial graphite, regenerated material and application thereof | 广西宸宇新材料有限公司 | 2025-05-27 | — | — | CN | claimed |
| US-20250140899-A1 | HIGH-VOLTAGE ION-MEDIATED FLOW/FLOW-ASSIST MANGANESE DIOXIDE-ZINC BATTERY | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2025-05-01 | — | — | US | claimed |
| CN-119852565-A | Complex electrolyte additive for battery, aqueous zinc ion battery electrolyte and aqueous zinc ion battery | 广西师范大学 | 2025-04-18 | — | — | CN | claimed |
| CN-119798040-A | Method for preparing fatty alcohol by catalytic oxidation of petroleum hydrocarbon | 西安石油大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119601792-A | Sulfonated lignin/gelatin composite hydrogel electrolyte, preparation method and water-based zinc ion battery | 郑州大学 | 2025-03-11 | — | — | CN | claimed |
| CN-119581696-A | Cross-linked sulfonated lignin/gelatin composite hydrogel electrolyte, preparation method and water-based zinc ion battery | 郑州大学 | 2025-03-07 | — | — | CN | claimed |
| EP-3339298-A1 | METHODS OF PREPARING OXA-BICYCLOALKENE | International Flavors & Fragrances Inc. (US) | 2018-06-27 | — | — | EP | claimed |
| US-20180170896-A1 | METHODS OF PREPARING OXA-BICYCLOALKENE | INT FLAVORS & FRAGRANCES INC (US) | 2018-06-21 | — | — | US | claimed |
| US-20160368837-A1 | METHODS OF PRODUCING PARA-XYLENE AND TEREPHTHALIC ACID | MICROMIDAS, INC. (US) | 2016-12-22 | — | — | US | claimed |
| US-9260359-B2 | Methods of producing para-xylene and terephthalic acid | MICROMIDAS, INC. (US) | 2016-02-16 | — | — | US | claimed |
| US-20150141695-A1 | METHODS OF PRODUCING PARA-XYLENE AND TEREPHTHALIC ACID | MICROMIDAS, INC. (US) | 2015-05-21 | — | — | US | claimed |
| US-20140266201-A1 | MAGNETIC FIELD PROBE FOR MRI WITH A FLUOROELASTOMER OR A SOLUTION OF A FLUORINE-CONTAINING COMPOUND | KONINKLIJKE PHILIPS N.V. (NL) | 2014-09-18 | — | — | US | claimed |
| EP-2584369-A1 | Magnetic field probe for MRI with a fluoroelastomer or a solution of a fluorine-containing compound | Koninklijke Philips Electronics N.V. (NL) | 2013-04-24 | — | — | EP | claimed |
| EP-1594835-A4 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS INC (US) | 2007-05-02 | — | — | EP | claimed |
| EP-1594835-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | Auspex Pharmaceuticals, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004064745-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS, INC. (US) | 2004-08-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180170896-A1 | METHODS OF PREPARING OXA-BICYCLOALKENE | OTC, AOC2, AOC3 | CA1 586/4885CA2 1367/4885CA7 640/4885 |
| US-20150141695-A1 | METHODS OF PRODUCING PARA-XYLENE AND TEREPHTHALIC ACID | DCXR, DDT, HPD | CA1 1384/4885CA2 3521/4885CA7 1816/4885 |
| US-20160368837-A1 | METHODS OF PRODUCING PARA-XYLENE AND TEREPHTHALIC ACID | DCXR, DDT, HPD | CA1 1384/4885CA2 3521/4885CA7 1816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.